Euroapi Sa Stock Net Income

EAPIF Stock  USD 2.53  0.00  0.00%   
As of the 12th of February 2026, Euroapi SA shows the Variance of 9.18, standard deviation of 3.03, and Mean Deviation of 0.9069. Euroapi SA technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Euroapi SA coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if Euroapi SA is priced favorably, providing market reflects its regular price of 2.53 per share. Please also check Euroapi SA information ratio, which is currently at (0.19) to verify the company can sustain itself at a future point.
Euroapi SA's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Euroapi SA's valuation are provided below:
Euroapi SA does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between Euroapi SA's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Euroapi SA should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Euroapi SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Euroapi SA 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Euroapi SA's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Euroapi SA.
0.00
11/14/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/12/2026
0.00
If you would invest  0.00  in Euroapi SA on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Euroapi SA or generate 0.0% return on investment in Euroapi SA over 90 days. Euroapi SA is related to or competes with Ion Beam, Northwest Biotherapeutics, 3-D Matrix, BioPorto, Clinuvel Pharmaceuticals, Kneat, and Immutep. Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in ... More

Euroapi SA Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Euroapi SA's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Euroapi SA upside and downside potential and time the market with a certain degree of confidence.

Euroapi SA Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Euroapi SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Euroapi SA's standard deviation. In reality, there are many statistical measures that can use Euroapi SA historical prices to predict the future Euroapi SA's volatility.
Hype
Prediction
LowEstimatedHigh
0.132.535.68
Details
Intrinsic
Valuation
LowRealHigh
0.142.795.94
Details

Euroapi SA February 12, 2026 Technical Indicators

Euroapi SA Backtested Returns

Euroapi SA secures Sharpe Ratio (or Efficiency) of -0.16, which denotes the company had a -0.16 % return per unit of risk over the last 3 months. Euroapi SA exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Euroapi SA's Variance of 9.18, standard deviation of 3.03, and Mean Deviation of 0.9069 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0685, which means not very significant fluctuations relative to the market. As returns on the market increase, Euroapi SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Euroapi SA is expected to be smaller as well. At this point, Euroapi SA has a negative expected return of -0.51%. Please make sure to confirm Euroapi SA's information ratio, skewness, as well as the relationship between the Skewness and day median price , to decide if Euroapi SA performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.49  

Average predictability

Euroapi SA has average predictability. Overlapping area represents the amount of predictability between Euroapi SA time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Euroapi SA price movement. The serial correlation of 0.49 indicates that about 49.0% of current Euroapi SA price fluctuation can be explain by its past prices.
Correlation Coefficient0.49
Spearman Rank Test-0.19
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Euroapi SA reported net income of (15.8 Million). This is 104.63% lower than that of the Healthcare sector and 106.64% lower than that of the Medical Devices industry. The net income for all United States stocks is 102.77% higher than that of the company.

Euroapi Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Euroapi SA's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Euroapi SA could also be used in its relative valuation, which is a method of valuing Euroapi SA by comparing valuation metrics of similar companies.
Euroapi SA is currently under evaluation in net income category among its peers.

Euroapi Fundamentals

About Euroapi SA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Euroapi SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Euroapi SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Euroapi SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Euroapi Pink Sheet

Euroapi SA financial ratios help investors to determine whether Euroapi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Euroapi with respect to the benefits of owning Euroapi SA security.